Competitive Landscape: Key Market Leaders and New Entrants in the Synthetic Biology Industry

The synthetic biology market is on track for remarkable expansion, driven by cutting-edge technologies and increasing demand across various industries. As innovation accelerates and new applications emerge, this market is set to transform sectors like healthcare, chemicals, and biofuels, paving the way for a more sustainable and efficient future. Let's explore the market valuation, key players, influential trends, and important segments that define this evolving industry.

Projected Market Value and Growth Trajectory in Synthetic Biology
The synthetic biology market is anticipated to experience rapid growth, reaching a valuation of $62.48 billion by 2030. This expansion corresponds to a compound annual growth rate (CAGR) of 18.2%. Several factors are driving this growth, including rising investments in bio-manufacturing, increasing demand for sustainable chemicals and fuels, the broadening scope of synthetic biology in healthcare, growing integration of AI-driven biological design, and clearer regulations around engineered organisms. Noteworthy trends shaping the market include the expanding use of CRISPR-based gene editing, bioinformatics-guided design tools, synthetic gene construction platforms, a strong emphasis on sustainable bio-based production, and enhanced automation in biological engineering workflows.

Download a free report of the synthetic biology market report:
https://www.thebusinessresearchcompany.com/report/synthetic-biology-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR

Emerging Industry Leaders in the Synthetic Biology Landscape
A variety of significant companies are shaping the synthetic biology market today. These include Thermo Fisher Scientific Inc, Danaher Corporation, Eurofins Scientific, Merck KGaA, Novozymes A/S, Agilent Technologies, New England Biolabs Inc, Precigen Inc, Amyris, Inc, Genscript Biotech Corporation, Codex Genetics, Cathay Biotech, Bota Biosciences, Bluepha, Spiber, OriCiro Genomics Inc, Provectus Algae, Puraffinity, Royal DSM NV, Colorifix, Phytoform Labs, Desktop Genetics, NanoSyrinx, Pulmobiotics S.L, EnginZyme, Chain Biotech, Nuclera Nucleics, Biosynthetics GmbH, Entelechon GmbH, Sloning BioTechnology GmbH, Prokarium Ltd, Synbio, Captor Therapeutics, Gero.ai, ARNA Genomics, Solvo Omixon, Soft flow, Algenol, Genomatica, Integrated DNA Technologies, Sana Biotechnology, Impossible Foods, Apeel Sciences, Twist Bioscience, Synlogic, Zymergen Inc, Ginkgo Bioworks, Codexis, Arzeda Corporation, Synthetic Genomics, Conagen, Dupont, Oxitec Ltd, Sentebiolab, GEEN Biotechnology Inc, and Genbiotek Biosistem Laboratory Ltd.

Significant Acquisition Enhancing Johnson & Johnson's Biotech Portfolio
In March 2024, Johnson & Johnson, a leading US pharmaceutical firm, completed its acquisition of Ambrx, Inc., a biotechnology company specializing in the design and development of site-specific protein and peptide therapeutics. Although the financial details were undisclosed, this move strengthens Johnson & Johnson's biopharmaceutical pipeline by enhancing protein and peptide engineering capabilities. It also broadens their innovative therapeutic portfolio and helps accelerate the development of next-generation biologics.

View the full synthetic biology market report:
https://www.thebusinessresearchcompany.com/report/synthetic-biology-global-market-report?utm_source=OpenPR&utm_medium=Paid&utm_campaign=Apr_PR

Innovative Trends Reshaping the Synthetic Biology Industry
Companies within the synthetic biology sector are increasingly focusing on developing customized solutions that accelerate the design-build-test cycle for tailored synthetic biology projects. A prime example is the launch of Integrated DNA Technologies' (IDT) Synthetic Biology Custom Solutions Program in June 2025. This service provides clients with direct access to IDT's scientists and engineers for bespoke synthetic DNA construct development instead of relying solely on standard catalog products. The program offers dedicated support for design-build-test workflows, uses IDT's 25,000-square-foot synthetic biology facility for custom manufacturing, accepts a wide variety of project types including complex genes and non-standard DNA fragments, and delivers faster turnaround times by eliminating strict high-throughput constraints. This approach empowers innovators to rapidly iterate and overcome challenges in R&D.

Detailed Segmentation of the Synthetic Biology Market
This report breaks down the synthetic biology market into key segments for detailed analysis:
1) Technology: Nucleotide Synthesis and Sequencing, Bioinformatics, Microfluidics, Genetic Engineering
2) Product Type: Oligonucleotides, Enzymes, Cloning and Assembly Kits, Xeno-Nucleic Acids (XNA), Chassis Organisms
3) Application: Pharmaceuticals and Diagnostics, Chemicals, Biofuels, Bioplastics, Other Applications

Further subcategories include:
- Nucleotide Synthesis and Sequencing: DNA Synthesis Technologies, Next-Generation Sequencing (NGS), Sanger Sequencing
- Bioinformatics: Software Tools for Genomic Data Analysis, Databases for Gene/Protein Information, Algorithms for Gene Editing and Design
- Microfluidics: Lab-On-A-Chip Technologies, Microfluidic Devices for Biological Assays, Applications in Drug Discovery and Diagnostics
- Genetic Engineering: CRISPR/Cas9 Technology, Recombinant DNA Technology, Synthetic Gene Construction and Assembly

These segments provide a comprehensive framework to understand the diverse components and applications driving the synthetic biology market forward.

Reach out to us:
The Business Research Company: https://www.thebusinessresearchcompany.com/,
Americas +1 310-496-7795,
Europe +44 7882 955267,
Asia & Others +44 7882 955267 & +91 8897263534,
Email us at info@tbrc.info.

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Learn More About The Business Research Company
With over 17500+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead.Our flagship product, the Global Market Model (GMM), is a premier market intelligence platform delivering comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.